Extent of MGMT promoter methylation modifies the effect of temozolomide on overall survival in patients with glioblastoma: a regional cohort study in Southeast Scotland
View ORCID ProfileMichael TC Poon, View ORCID ProfileShivank Keni, Vineeth Vimalan, Chak Ip, View ORCID ProfileColin Smith, View ORCID ProfileSara Erridge, View ORCID ProfileChristopher J Weir, View ORCID ProfilePaul M Brennan
doi: https://doi.org/10.1101/2021.07.22.21260997
Michael TC Poon
1Centre for Medical Informatics, Usher Institute, University of Edinburgh
2Department of Clinical Neuroscience, Royal Infirmary of Edinburgh, NHS Lothian
3Cancer Research UK Brain Tumour Centre of Excellence, CRUK Edinburgh Centre, University of Edinburgh
Shivank Keni
4Edinburgh Medical School, University of Edinburgh
Vineeth Vimalan
2Department of Clinical Neuroscience, Royal Infirmary of Edinburgh, NHS Lothian
Chak Ip
5Royal Infirmary of Edinburgh, NHS Lothian
Colin Smith
6Centre for Comparative Pathology, University of Edinburgh
Sara Erridge
7Clinical Oncology, Western General Hospital, NHS Lothian
Christopher J Weir
8Edinburgh Clinical Trials Unit, Usher Institute, University of Edinburgh
Paul M Brennan
2Department of Clinical Neuroscience, Royal Infirmary of Edinburgh, NHS Lothian
3Cancer Research UK Brain Tumour Centre of Excellence, CRUK Edinburgh Centre, University of Edinburgh
9Translational Neurosurgery, Centre for Clinical Brain Sciences, University of Edinburgh
Data Availability
Please direct data request to the corresponding author.
Posted July 25, 2021.
Extent of MGMT promoter methylation modifies the effect of temozolomide on overall survival in patients with glioblastoma: a regional cohort study in Southeast Scotland
Michael TC Poon, Shivank Keni, Vineeth Vimalan, Chak Ip, Colin Smith, Sara Erridge, Christopher J Weir, Paul M Brennan
medRxiv 2021.07.22.21260997; doi: https://doi.org/10.1101/2021.07.22.21260997
Extent of MGMT promoter methylation modifies the effect of temozolomide on overall survival in patients with glioblastoma: a regional cohort study in Southeast Scotland
Michael TC Poon, Shivank Keni, Vineeth Vimalan, Chak Ip, Colin Smith, Sara Erridge, Christopher J Weir, Paul M Brennan
medRxiv 2021.07.22.21260997; doi: https://doi.org/10.1101/2021.07.22.21260997
Subject Area
Subject Areas
- Addiction Medicine (317)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2318)
- Dermatology (205)
- Emergency Medicine (373)
- Epidemiology (11653)
- Forensic Medicine (10)
- Gastroenterology (687)
- Genetic and Genomic Medicine (3656)
- Geriatric Medicine (344)
- Health Economics (625)
- Health Informatics (2340)
- Health Policy (922)
- Hematology (337)
- HIV/AIDS (765)
- Medical Education (362)
- Medical Ethics (102)
- Nephrology (394)
- Neurology (3407)
- Nursing (193)
- Nutrition (512)
- Oncology (1787)
- Ophthalmology (529)
- Orthopedics (212)
- Otolaryngology (284)
- Pain Medicine (227)
- Palliative Medicine (66)
- Pathology (442)
- Pediatrics (1014)
- Primary Care Research (411)
- Public and Global Health (6047)
- Radiology and Imaging (1243)
- Respiratory Medicine (816)
- Rheumatology (373)
- Sports Medicine (319)
- Surgery (391)
- Toxicology (50)
- Transplantation (171)
- Urology (144)